Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chinese Journal of Cancer Research is Scopus-indexed (Q1, CiteScore 7.9), WoS SCIE. Published by Chinese Journal of Cancer Research Co., Ltd. and Peking University Cancer Hospital and Institute.
Checked against the index lists dated .
ISSN 1000-9604Verify ISSN ↗1993-0631Verify ISSN ↗
Publisher: Chinese Journal of Cancer Research Co., Ltd. and Peking University Cancer Hospital and Institute
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 74 / 428 | 82nd | Q1 |
| Cancer Research | 64 / 233 | 72nd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1988–1996 (also 1998–2017, 2021–present), best quartile Q1, CiteScore 7.9.
Chinese Journal of Cancer Research is Q1 in Oncology (rank 74 of 428) and Q2 in Cancer Research (rank 64 of 233), by CiteScore 2025.
Chinese Journal of Cancer Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.9, which places it in quartile Q1 at the 82nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.406, quartile Q1, with an H-index of 51.
Chinese Journal of Cancer Research is published by Chinese Journal of Cancer Research Co., Ltd. and Peking University Cancer Hospital and Institute. Its print ISSN is 1000-9604 and its online ISSN is 1993-0631.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Chinese Journal of Cancer Research has an h-index of 61 and a 2-year mean of 5.48 citations per paper (OpenAlex). Its Scopus CiteScore is 7.9, quartile Q1. On 2-year citations it ranks #48 of 424 Scopus journals in Oncology.
Chinese Journal of Cancer Research published 80 papers in 2025; its busiest recent year was 2019 with 88. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2025–2026), authors are most often from China (82.5%), South Korea (5.3%) and United States (4.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.